PLX · Categories · 13G

PLX - SEC Schedule 13G filings

Protalix BioTherapeutics Inc. (DE) (PLX) sec schedule 13g filings - real-time wire coverage filtered to 13G only.

Recent 13G for PLX

• 594d
  Amendment: SEC Form SC 13G/A filed by Protalix BioTherapeutics Inc. (DE)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 891d
  SEC Form SC 13G/A filed by Protalix BioTherapeutics Inc. (DE) (Amendment)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1255d
  SEC Form SC 13G/A filed by Protalix BioTherapeutics Inc. (DE) (Amendment)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1463d
  SEC Form SC 13G filed by Protalix BioTherapeutics Inc. (DE)

  SC 13G - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1578d
  SEC Form SC 13G/A filed by Protalix BioTherapeutics Inc. (DE) (Amendment)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1581d
  SEC Form SC 13G/A filed by Protalix BioTherapeutics Inc. (DE) (Amendment)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1592d
  SEC Form SC 13G/A filed by Protalix BioTherapeutics Inc. (DE) (Amendment)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1777d
  SEC Form SC 13G/A filed by Protalix BioTherapeutics, Inc. (Amendment)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1822d
  SEC Form SC 13G/A filed by Protalix BioTherapeutics, Inc. (Amendment)

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1941d
  SEC Form SC 13G/A filed

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1941d
  SEC Form SC 13G/A filed

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1945d
  SEC Form SC 13G filed

  SC 13G - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1948d
  SEC Form SC 13G/A filed

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1949d
  SEC Form SC 13G/A filed

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)
• 1949d
  SEC Form SC 13G/A filed

  SC 13G/A - Protalix BioTherapeutics, Inc. (0001006281) (Subject)

Other PLX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends